CD19 and acute lymphoblastic leukemia: treated fifteen B-ALL or B-cell lymphoma patients with CD19 CAR-T cells and found that patients with low monocytic myeloid-derived suppressor cell counts (CD14+CD33+HLA-DR cells) achieved better response.